That is, any factor that affects diagnostic intensity and particularly PSA testing will inevitably affect observed prostate cancer incidence, making it difficult to distinguish between factors that influence disease development and those that influence disease detection. The gene discussed is KLK3; the disease is Familial prostate cancer.